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ABSTRACT
Objective: The objective of this work is to synthesize and evaluate some novel 1,2,4-triazoles.
Methods: Procedure includes synthesis of triazole compounds followed by biological evaluations. The synthesis was carried out in six steps with 
p-bromobenzoic acid as starting material and converting to ester and then to hydrazide. Hydrazide was then converted to 4-amino triazole. The 
amino triazole was then linked to different secondary amines using chloroacetyl chloride as the linking agent. All the synthesized compounds were 
characterized through Fourier transform infrared spectroscopy, gas chromatography-mass spectroscopy, and nuclear magnetic resonance. Further, 
the compounds were taken out for biological evaluations. To explore their effects, experiments were conducted on various micro- as well as macro-
organisms. The toxicity profile was also tested in accordance with OECD 425 guideline on Wistar albino rats.
Results: The compounds were examined for antibacterial as well as antifungal activities. Among the all compound T71, T73, and T75 exhibited 
antibacterial activity, and compound T71 showed antifungal activity as well. The evaluation was also carried out for anthelmintic activities. The 
compounds were treated on Pheretima posthuma at various concentrations to explore their vermifuge and vermicidal action. The triazole linked with 
1-methylpiperazine was found to have comparable activity to that of reference standards.
Conclusion: Triazoles are a most potent assemblage of fungal retardants. But depending on their substituents, they also have diverse pharmacological 
values. In this study, the compound T71 showed promising antimicrobial as well as anthelmintic action. Hence, it can be considered as a lead compound 
for further researches.
Keywords: Anthelmintic, Antimicrobial, Triazole, Piperazine, Albendazole.
INTRODUCTION
Parasitic infections are the serious health crunch in the tropical 
regions including Asian continents. Helminths produce chronic illness, 
malnutrition, anemia, and immune-mediated inflammatory changes in 
human beings as well as in other animals [1]. There are many types of 
helminths out of which intestinal worms are most common. Intestinal 
worms are parasites that can infect gut lumen and may reach to the 
blood stream and other vital organs. There is a group of anti-helminthic 
drugs that expel parasitic worms from the body either by paralyzing or 
killing them without causing significant damage to the host. Hence, they 
may have vermifuge or vermicidal action [2]. Vermifuges are the drugs 
that cause expulsion of the worms from gut whereas vermicidals have 
a tendency to kill them [3]. World health organization recommends 
anti-helminthic medications such as benzimidazoles and praziquantel 
for medical care, even during pregnancy in the endemic regions, 
particularly where the prevalence and hygiene related risk factor is 
high [4]. On the basis of scientific literature we find that a majority 
of antiparasitic drugs are heterocyclic in nature [5]. They provide 
scaffolds on which pharmacophores can be arranged to obtain potent 
and desirable activity.
Chemistry of heterocyclic compounds constitutes one of the 
latitudinous and outstretched areas of biological system. They have 
great biochemical significance. Many natural, as well as synthetic 
drugs, are heterocyclic in nature. Naturally occurring heterocyclic 
compounds are extremely common as, for example, DNA, RNA, enzyme 
cofactors, plant pigments, hemoglobin, vitamins, and alkaloids [6]. The 
most common anthelmintic drug benzimidazole is also heterocyclic 
in nature. It consists of the fusion of benzene and imidazole. Many 
anthelmintic drugs as, for example, albendazole (ALB), mebendazole, 
and triclabendazole belong to the class benzimidazole [7].
In the past few decades, the influence of triazoles in different biological 
activities has grown up rapidly. It has become evident from the recent 
researches that the triazoles are not only antimicrobial or antifungal 
but also have many pharmacological activities [8]. Basic nucleus 
triazole, when fused to another heterocyclic ring, leads to widespread 
action and diverse biological applications such as antidepressant [9], 
anti-inflammatory [10], antitumor [11], and antiviral action [12]. 
Triazoles are distinguished class of heterocyclic compounds having 
broad spectrum biological properties. Hence, there has been substantial 
interest of researchers in the development of new triazole compounds. 
In view of this, an attempt has been made to explore pharmacological 
action of some newly synthesized triazoles.
METHODS
All the test compounds were synthesized by the method reported 
by us [1-4]. Chemicals and reagents utilized in the synthesis were 
procured from Sigma-Aldrich, Merck, and Spectrochem. The synthesis 
was carried out in six steps. The initial reactant compound was 
4-bromobenzoic acid, which was converted into 4-ethanoylamino-3-
mercapto-5-(4-bromo) phenyl-1,2,4-triazole via six steps of synthesis 
(Figs. 1 and 2).
Step 1: Synthesis of methyl ester [13]
4-bromobenzoic acid (0.1 mol, 20.1 g) was taken in a round bottom 
flask with methanol (100 mL). Concentrated sulfuric acid (2 mL) 
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was added to it. The reaction mixture was refluxed for 6 hrs. 
Excess of methanol was then distilled off at reduced pressure. The 
content was allowed to cool and transferred to separating funnel. 
The synthesized ester was extracted out using carbon tetrachloride. 
The mixed organic layer was washed with 5% solution of sodium 
bicarbonate to get rid of unreacted aromatic acid. The excess of 
carbon tetrachloride was then distilled off under reduced pressure 
to get pure ester, which was recrystallized using methanol. Yield: 
19.5 g (91%), mp 77-81°C.
Step 2: Synthesis of acid hydrazide [14]
Acid hydrazide was synthesized by mixing methyl 4-bromobenzoate 
(0.1 mol, 21.5 g) with hydrazine hydrate (0.15 mol, 5.7 mL) in an 
alcoholic medium (methanol 100 mL). The reaction mixture was 
refluxed for 4-6 hrs. Excess of alcohol was distilled off under reduced 
pressure. The obtained hydrazide was recrystallized using methanol. 
Yield: 20.2 g (94%), mp 166-169°C.
Step 3: Synthesis of potassium 3-aroyl dithiocarbazate [15]
The synthesis of dithiocarbazate salt was carried out by reacting the 
hydrazide with alcoholic potassium hydroxide (0.15 mol, 8.4 g) along 
with carbon disulfide (0.15 mol, 9 mL). The alcoholic potassium 
hydroxide was prepared by mixing absolute ethanol (75 mL) with 
potassium hydroxide (8.4 g). The reaction mixture was stirred for 16 hrs 
at room temperature. The product was filtered off through Whatman 
paper and washed with dry ether to remove unreacted carbon disulfide. 
Further, the filtered salt was dried at room temperature and taken out 
for the next step.
Step 4: Synthesis of 4-amino-3-mercapto-5-phenyl-1,2,4-triazole [16,17]
The thiocarbazate salt was refluxed with hydrazine hydrate 
(0.2 mol, 7.6 mL) and water (6 mL) in ethanol medium for 2-3 hrs. 
The color of reaction mixture changed to green, hydrogen sulfide gas 
evolved was tested by Lead acetate paper. The resultant homogeneous 
solution was allowed to cool and diluted with cold water (100 mL). The 
Fig. 1: Scheme of synthesis
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product was acidified with concentrated hydrochloric acid. A shifting of 
pH toward acid range resulted in heavy precipitation. The precipitated 
solid was filtered off and washed with distilled water. The product was 
recrystallized from equivolume ethanol-water mixture. Yield: 13.8 g 
(71.9%), mp 205-207°C.
Step 5: Synthesis of 4-chloroacyl amino-3-mercapto-5-phenyl-
1,2,4-triazole [18]
The synthesized triazole of the previous step was acetylated with 
chloroacetyl chloride (0.11 mol, 8.75 ml) in dioxane medium. The reaction 
mixture was refluxed for 1 hr. The product was allowed to cool and poured 
on crushed ice. The precipitated product was filtered and repetitively 
washed with cold distilled water. Yield: 18.3 g (68%), mp 182-184°C.
Step 6: Synthesis of 4-(substituted ethanoyl)-3-mercapto-5-
phenyl-1,2,4-triazole [19]
The compound (0.025 mole) obtained from step “5” was solubilized in 
very little amount of dimethyl sulfoxide (DMSO) and then mixed with the 
respective amine (0.030 mole) along with the triethylamine (0.030 mole). 
The reaction mixture was taken in benzene (75 mL) and refluxed for 4 hrs. 
The precipitated triethylamine hydrochloride was separated out. Benzene 
was distilled off under reduced pressure. The product was further treated 
with ice cold distilled water, and the precipitated compound was filtered 
out using filter paper. Purification of the compound was done by repeated 
crystallization through appropriate solvent.
Melting points and percentage yield of the synthesized compounds 
were determined. The structures were elucidated by CHN-analysis, 
Fourier transform infrared (FTIR) spectroscopy, [13] C-nuclear 
magnetic resonance (NMR), 1H-NMR, and gas chromatography-mass 
spectroscopy techniques. The physical and spectral data are arranged 
in Tables 1 and 2, respectively.
BIOLOGICAL ACTIVITIES
Screening tests (in-vitro) were carried out to explore the anthelmintic 
and antimicrobial activities of the synthesized compounds. Pheretima 
posthuma (in-vitro model) for anthelmintic activity and disc diffusion 
methods for antimicrobial activity were used accomplished with vehicle 
control and standard groups. The reference drugs as, for example, ALB, 
ciprofloxacin, and fluconazole were obtained from Cipla Limited, India. 
The P. posthuma (test organism for anthelmintic activity) was collected 
from the moist soil of the river bank of Yamuna. Micro-organisms for 
antimicrobial activity were obtained from Microbial Type Culture 
Collection (MTCC) Chandigarh. Other required ingredients and 
chemicals were procured from HiMedia, India.
Anthelmintic activity
The anthelmintic activity was carried out through in-vitro 
method [20-22] using P. posthuma. Since adult P. posthuma has 
anatomical and physiological resemblance with the intestinal 
roundworm parasites, the experiment was conducted on that test 
animal only. P. posthuma was placed in a petri dish containing test 
drugs at two different concentrations (10 and 20 mg/mL). The time of 
paralysis was recorded when no locomotion of any sort was observed 
except when the worm was shaken vigorously. The time of death was 
Fig. 2: Synthesized compounds
142
Asian J Pharm Clin Res, Vol 10, Issue 6, 2017, 139-145
 Gupta and Mishra 
confirmed after ascertaining that worm neither moved when shaken 
nor when given external stimuli on any part of his body. The observation 
was carried out in triplet for mean paralysis time and death time.
Antimicrobial evaluation
The synthesized compounds were tested for antibacterial as well as 
antifungal activities. The antibacterial activity was carried out against 
Staphylococcus aureus (MTCC-3160), Bacillus subtilis (MTCC-10619), 
Pseudomonas aeruginosa, (MTCC-424) and Escherichia coli (MTCC-
443). Antifungal activity was carried out using Aspergillus niger (MTCC-
9687), Candida albicans (MTCC-1637), and Fusarium oxysporum 
(MTCC-2087) fungal strains.
Antibacterial activity
Disc diffusion method [23-25] was performed in nutrient agar media. 
The agar media was inoculated with 0.1 mL (diluted in 0.4 mL of 
Table 1: List of the synthesized compounds with nitrogen (%) and Rf
General structure
Code -Ar Amine- Rf % yield mp. (°C) Nitrogen % found (calculated)
T71 0.60 65 216-218 20.21 (20.43)
T72 0.79 69 208-212 18.22 (17.07)
T73 0.81 74 227-230 17.09 (17.24)
T74 0.72 63 215-217 17.38 (17.07)
T75 0.64 55 210-213 18.05 (18.32)
Solvent used for the determination of Rf value – solvent system used: n-hexane: ethyl acetate (6:4, v/v)
Table 2: Spectral data of synthesized compounds
Compound FTIR (KBr, cm−1) 1H‑NMR (DMSO‑d6) δ ppm 13C‑NMR (DMSO‑d6) δ ppm GC-MS, 
m/z [M+]
T71 3253 (N-H), 3095 (C-H Ar.), 
2935 (C-H Methyl), 2594 (S-H), 
1629 (C=O), 1529 (C=C), 
1497 (C=N), 1486 (C-H bend.), 
1172 (C-N)
2.38 (s, 3H, CH3), 2.58-2.62 (m, 8H, 
CH2-piperazine), 3.40 (s, 2H, COCH2), 
7.77-7.79 (d, J=9.1, 2×1H, Ar-H), 
8.14-8.16 (d, J=9.2, 2×1H, Ar-H), 
9.87 (s, 1H, CONH), 13.96 (s, 1H, SH)
174.8 (NHCO), 167.0 (C5), 148.4 (C3), 
131.3 (C3’ & C5’), 129.8 (C2’ & C6’), 
124.9 (C1’), 124.1 (C4’), 59.4 (COCH2), 
54.8 (Cb & Cc), 53.1 (Ca & Cd), 45.0 (Ce)
410
T72 3320 (N-H), 3134 (C-H Ar.), 
2974 (C-H Methyl), 2563 (S-H), 
1618 (C=O), 1506 (C=C), 
1486 (C=N), 1477 (C-H bend.), 
1240 (C-N)
1.21 (s, 3H, CH3-piper.), 
1.84-1.98 (m, 9H, CH, CH2), 3.43 (s, 
2H, COCH2), 7.85-7.88 (d, J=9.2, 2H, 
Ar-H), 8.08-8.10 (d, J=9.0, 2H, Ar-H), 
9.86 (s, 1H, CONH), 13.97 (s, 1H, SH)
175.4 (NHCO), 167.1 (C5), 148.4 (C3), 
130.7 (C3’ & C5’), 129.1 (C2’ & C6’), 
125.1 (C1’), 124.9 (C4’), 58.4 (COCH2), 
52.5 (Ca & Ce), 34.1 (Cb & Cd), 30.8 (Cc), 
22.8 (Cf)
409
T73 3312 (N-H), 3132 (C-H Ar.), 
2958 (C-H Methylene), 2594 (S-H), 
1628 (C=O), 1532 (C=C), 
1493 (C=N), 1466 (C-H bend.), 
1231 (C-N)
2.44-2.48 (m, 8H, CH2-piperazine), 
3.40 (s, 2H, COCH2), 3.75 (s, 2H, 
CH2-Ar), 7.49-7.49 (m, 5H, Ar-H), 
7.56-7.59 (d, J=9.2, 2H, Ar-H), 
8.15-8.18 (d, J=9.2, 2H, Ar-H), 
9.87 (s, 1H, CONH), 13.91 (s, 1H, SH)
174.8 (NHCO), 167.1 (C5), 148.2 (C3), 
137.3 (Ca’), 135.4 (C3’ & C5’), 129.9 (Cb’ 
& Cf’), 129.7 (Cc’ & Ce’), 128.3 (C2’ & 
C6’), 127.0 (Cd’), 124.9 (C1’), 124.0 (C4’), 
62.5 (Ce), 58.7 (COCH2), 52.7 (Ca & Cd), 
52.5 (Cb & Cc)
486
T74 3301 (N-H), 3104 (C-H Ar.), 
2972 (C-H Methyl), 2557 (S-H), 
1656 (C=O), 1540 (C=C), 
1491 (C=N), 1465 (C-H bend.), 
1231 (C-N)
1.19 (s, 3H, CH3-piper.), 
1.92-1.96 (m, 9H, CH, CH2), 3.39 (s, 
2H, COCH2), 7.73-7.75 (d, J=9.2, 2H, 
Ar-H), 8.13-8.15 (d, J=9.2, 2H, Ar-H), 
9.86 (s, 1H, CONH), 13.95 (s, 1H, SH)
177.1 (NHCO), 167.1 (C5), 148.3 (C3), 
131.2 (C3’ & C5’), 129.9 (C2’ & C6’), 
124.9 (C1’), 124.2 (C4’), 58.8 (COCH2), 
56.4 (Ce), 50.1 (Ca), 34.5 (Cd), 24.4 (Cc), 
24.1 (Cb), 18.5 (Cf)
409
T75 3296 (N-H), 3125 (C-H Ar.), 
2971 (C-H Methylene), 2591 (S-H), 
1647 (C=O), 1546 (C=C), 
1496 (C=N), 1461 (C-H bend.), 
1238 (C-N)
1.76 (m, 2×2H, CH2-pyrr.), 
2.55-2.58 (t, 2×2H, CH2-pyrr.), 
3.44 (s, 2H, COCH2), 7.64-7.67 (d, 
J=8.9, 2H, Ar-H), 8.46-8.49 (d, J=9.1, 
2H, Ar-H), 9.87 (s, 1H, CONH), 
13.92 (s, 1H, SH)
176.0 (NHCO), 167.3 (C5), 148.6 (C3), 
132.6 (C3’ & C5’), 129.9 (C2’ & C6’), 
125.8 (C1’), 124.9 (C4’), 58.9 (COCH2), 
54.8 (Ca & Cd), 26.7 (Cb & Cc)
381
DMSO: Dimethyl sulfoxide, FTIR: Fourier transform infrared, NMR: Nuclear magnetic resonance, GC-MS: Gas chromatography-mass spectroscopy
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nutrient broth) of bacterial suspension containing 10 [8] cells/mL, 
equivalent to McFarland Nephelometer standard number 0.5. Whatman 
paper discs (diameter 5 mm) were placed on the pre-inoculated agar 
media. Then, the discs were impregnated with a fixed volume (30 µL) 
of compound dissolved in dimethylsulfoxide at different dilutions (6, 
3, and 1.5 mg/mL). The plates were incubated at 35±1°C for 24 hrs. 
The compound less discs with DMSO were used as a control. Zone 
diameter was measured in millimeter. Further, the minimum inhibitory 
concentration (MIC) of the synthesized compounds was determined by 
broth dilution method [26,27].
Antifungal activity
Similarly, the newly synthesized compounds were tested for antifungal 
activity. This activity was conducted using disc diffusion method [28-30]. 
Sabouraud dextrose agar media was used for C. albicans and A. niger, 
whereas potato sucrose agar was utilized as culture media against 
F. oxysporum. The tests were performed for all compounds at three 
dilutions. Zone of inhibition was measured in millimeter. To obtain MIC, 
the broth dilution method was followed [31].
ACUTE ORAL TOXICITY (AOT) STUDY
To explore the toxicity of the synthesized compounds, AOT studies 
were performed in accordance with OECD 425 guidelines [32]. An 
experiment conducted on Wistar albino rats. The test animals were 
critically observed for 24 hrs and further for 14 days. The taken 
compounds did not produce any toxic effect even at 2000 mg/kg dose 
level (Fig. 3).
RESULTS
The compounds (T71-T75) were synthesized according to the scheme 
shown in Fig. 1. 4-bromobenzoic acid was converted into ester using 
methanol and concentrated sulfuric acid. In the next step, the ester 
treated with hydrazine hydrate and the hydrazide was synthesized. The 
hydrazide was cyclized into triazole with the help of alcoholic potassium 
hydroxide and carbon disulfide. The synthesized triazole (Compound V) 
treated with chloroacetyl chloride and in the past step, condensed with 
secondary amines to form the final compounds (T71-T75). All the 
synthesized compounds were characterized on the basis of FTIR, MASS, 
and NMR. In infrared spectroscopy, the final compounds exhibited C=N 
stretching band between 1486 and 1496/cm and C-N stretching band 
between 1072 and 1240/cm, which signify the presence of 1,2,4-triazole 
ring. The series also showed absorption between 1618-1656/cm 
and 3253-3320/cm, which is a typical feature of C=O stretching and 
N-H stretching of the amide group. The presence of absorption band 
between 3095-3134/cm and 2557-2594/cm was a clear evidence for 
aromatic C-H stretching and S-H stretching, respectively. In1H-NMR, 
the singlets of CONH and SH were observed in the range of δ 9.86-
9.87 ppm and δ 13.91-13.96 ppm, respectively. In [13] C-NMR spectra, 
C-5 and C-3 of the triazole nucleus were seen in the range of δ 167 ppm 
and δ 148 ppm. Carbonyl and methylene carbon of NHCOCH2N were 
observed at δ 174-177 ppm and δ 58-59 ppm.
The compounds were evaluated for biological activities. Anthelmintic 
activity of the series has exhibited in terms of time of paralysis and time 
of death on P. posthuma. Compound T71 was found to be most effective 
vermifuge as well as vermicidal. It exhibited maximum potency with 
24 minutes paralysis time and 37.33 minutes of death time at 20 mg/mL 
concentration. It showed significant activity at a dose 20 mg/mL (Table 3).
The compounds were also evaluated for antimicrobial activities using 
disc diffusion method at three concentrations. The zone of inhibition, 
as well as MIC, was observed. It was found that all the compounds 
possess antimicrobial activities. The compound T71 and T73 exhibited 
maximum potency of inhibition against the taken flora. They inhibit the 
growth of S. aureus and B. subtilis in notable way (Table 4-7).
The compound T73 showed antimicrobial activities against all the 
selected strains in a moderate manner whereas compound T73 showed 
a better effect against gram-positive bacteria. The significant result of 
antifungal activity was shown by T71, T73, and T75. Out of these, the 
inhibition produced by T71 was most promising.
DISCUSSION
Triazoles are an important class of heterocyclic compounds having 
diversified biological activities.
Triazoles available for accepted clinical use accommodate fluconazole, 
itraconazole, voriconazole and posaconazole. Although they all 
have similarity in their biological activities, but they have variable 
pharmacokinetics and physiological instability. Almost all are accepted 
for the prevention as well as treatment of invasive fungal infections. In 
this study, the amine linked triazoles were taken for dual evaluations. It 
is well-documented the fact that triazoles are known for their antifungal 
properties, whereas piperazine (PZC) citrate itself has very significant 
anthelmintic potential. Hence, the test compounds were taken for 
anthelmintic as well as for antimicrobial evaluations. The newly prepared 
compounds were screened for their acute toxicity in accordance with 
OECD 425 guideline. Subsequently, the compounds were also evaluated 
for anthelmintic, antifungal, and antibacterial properties. Appreciable 
effects were revealed by the compounds. The results were comparable 
with the reference drugs. The observation revealed that at the terminal 
position the compound with PZC group has greater potency as compared 
to the other compounds of the series. Thus, it can be said that compound 
T71 has not only antimicrobial activities but also anthelmintic action 
as well. SAR study of the synthesized compounds indicates that the 
secondary amine at terminal carbon has lead role and hence it can be 
considered as a pioneer work for future investigations.
Fig. 3: Acute oral toxicity study (OECD 425 guideline)
Table 3: Anthelmintic activity of the synthesized compounds
Test 
compound
Time of paralysis and death
Paralysis time (min) Death time (min)
10 mg/mL 20 mg/mL 10 mg/mL 20 mg/mL
Control - - - -
T71 26.33±1.53 23.00±1.00 42.33±2.52 37.33±2.08
T72 52.33±1.53 44.33±0.58 60.33±2.52 50.00±1.73
T73 79.33±1.53 72.33±2.52 97.67±2.08 89.00±3.61
T74 80.33±2.52 73.33±1.53 96.33±1.53 87.67±2.52
T75 92.33±2.52 87.33±2.52 103.67±1.53 92.67±2.52
PZC 31.33±1.53 23.33±2.08 89.33±0.58 77.67±1.53
ALB 24.00±2.00 17.33±2.52 32.67±2.08 26.33±0.58
All the values are in mean±SD (n=3), SD: Standard deviation, PZC: Piperazine, 
ALB: Albendazole
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CONCLUSION
It has been revealed that the triazoles linked with secondary amines 
have dose-dependent biological activities. In conclusion, this study 
reports on the anthelmintic as well as the antifungal potential of the 
triazole compounds. Compounds T71, T73, and T75 are active against 
C. albicans, A. niger and F. oxysporum, whereas compound T71 and T73 
are active against S. aureus and B. subtilis. Anthelmintic potential was 
manifested in terms of paralysis time and death time of P. posthuma. 
Table 4: Antibacterial activity of synthesized compounds (zone of inhibition)
Compounds Zone of inhibition (mm)
Code Conc (mg/mL) S. aureus B. subtilis P. aeruginosa E. coli
T71 1.5 11.00±0.36 6.67±0.21 7.00±0.36 7.33±0.56
3.0 12.67±0.21 7.67±0.21 8.33±0.21 8.67±0.21
6.0 13.33±0.21 9.33±0.56 9.67±0.21 10.00±0.36
T72 1.5 7.33±0.21 8.00±0.36 5.67±0.21 6.67±0.21
3.0 9.00±0.36 9.67±0.21 6.67±0.21 7.33±0.21
6.0 10.67±0.21 10.33±0.21 7.00±0.36 8.00±0.36
T73 1.5 10.33±0.42 6.67±0.21 5.33±0.21 5.67±0.21
3.0 11.67±0.21 7.67±0.21 7.33±0.21 6.67±0.21
6.0 12.33±0.21 8.67±0.42 8.33±0.21 7.33±0.21
T74 1.5 7.67±0.21 8.33±0.21 6.00±0.36 8.00±0.36
3.0 8.33±0.21 10.00±0.36 7.67±0.21 9.67±0.21
6.0 10.33±0.56 11.33±0.21 8.00±0.36 10.00±0.36
T75 1.5 10.00±0.36 7.00±0.36 5.33±0.21 5.67±0.21
3.0 11.67±0.56 8.33±0.21 6.67±0.21 7.33±0.42
6.0 12.33±0.21 9.67±0.21 8.33±0.56 8.67±0.21
Control DMSO, 30 µL - - - -
Ciprofloxacin 1.5 18.67±0.21 21.33±0.21 23.67±0.56 12.67±0.21
All the values are in mean±SEM (n=6). S. aureus (MTCC No: 3160), B. subtilis (MTCC No: 10619), E. coli (MTCC No: 443), P. aeruginosa (MTCC No: 424). DMSO: Dimethyl 
sulfoxide, SEM: Standard error of the mean, S. aureus: Staphylococcus aureus, B. subtilis: Bacillus subtilis, P. aeruginosa: Pseudomonas aeruginosa, E. coli: Escherichia coli, 
MTCC: Microbial Type Culture Collection
Table 5: MIC of synthesized compounds referring antibacterial activity
Compounds MIC, µg/mL
S. aureus B. subtilis P. aeruginosa E. coli
T71 125 500 500 500
T72 500 250 ˃500 500
T73 125 500 ˃500 ˃500
T74 500 250 ˃500 500
T75 125 500 ˃500 ˃500
Control - - - -
Ciprofloxacin 15.62 15.62 15.62 31.25
S. aureus (MTCC No: 3160), B. subtilis (MTCC No: 10619), E. coli (MTCC No: 443), P. aeruginosa (MTCC No: 424). S. aureus: Staphylococcus aureus, 
B. subtilis: Bacillus subtilis, P. aeruginosa: Pseudomonas aeruginosa, E. coli: Escherichia coli, MIC: Minimal inhibitory concentration, MTCC: Microbial Type Culture 
Collection
Table 6: Antifungal activity of synthesized compounds (zone of inhibition)
Compounds Zone of inhibition (mm)
Code Concentration (mg/mL) C. albicans A. niger F. oxysporum
T71 1.5 18.67±0.21 18.33±0.22 13.33±0.21
3.0 19.50±0.22 19.17±0.17 14.50±0.22
6.0 20.50±0.22 20.33±0.21 15.33±0.21
T72 1.5 9.33±0.21 8.00±0.26 7.17±0.31
3.0 10.83±0.31 9.67±0.21 8.83±0.31
6.0 11.67±0.21 10.33±0.21 9.33±0.21
T73 1.5 14.67±0.33 13.00±0.26 11.50±0.22
3.0 15.33±0.21 14.67±0.21 12.33±0.21
6.0 16.67±0.21 15.33±0.33 13.67±0.21
T74 1.5 7.50±0.22 6.67±0.21 7.33±0.21
3.0 8.83±0.30 7.83±0.17 8.67±0.21
6.0 10.00±0.36 8.33±0.21 10.00±0.25
T75 1.5 6.83±0.30 7.17±0.31 8.67±0.33
3.0 7.67±0.21 8.00±0.26 9.33±0.21
6.0 8.67±0.21 9.17±0.30 11.00±0.26
Control DMSO, 30 µL - - -
Fluconazole 1.5 24.33±0.21 23.33±0.42 19.67±0.21
All the values are in mean±SEM (n=6). C. albicans (MTCC No: 1637), A. niger (MTCC No: 9687), F. oxysporum (MTCC No: 2087). SEM: Standard error of the mean, 
DMSO: Dimethyl sulfoxide, MIC: Minimal inhibitory concentration, C. albicans: Candida albicans, A. niger: Aspergillus niger, F. oxysporum: Fusarium oxysporum, 
MTCC: Microbial Type Culture Collection
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The compound T71 was found to be more effective against the taken 
organism. Thus, in this study, we investigated the antimicrobial as well 
as antihelminthic activities of some newly synthesized triazoles.
In view of the above result and discussion, we conclude that the 
synthesized triazoles have a novel biological action against micro-
organisms as well as parasites. These results will serve as preliminary 
finding for further advance studies.
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Table 7: MIC of synthesized compounds referring antifungal 
activity
Compounds MIC, µg/mL
C. albicans A. niger F. oxysporum
T71 31.25 31.25 125
T72 250 250 250
T73 125 125 125
T74 250 500 250
T75 500 250 250
Control (DMSO 30 µL) - - -
Fluconazole 7.81 7.81 15.61
C. albicans (MTCC No: 1637), A. niger (MTCC No: 9687), F. oxysporum (MTCC 
No: 2087). MIC: Minimal inhibitory concentration, DMSO: Dimethyl sulfoxide, 
C. albicans: Candida albicans, A. niger: Aspergillus niger, F. oxysporum: Fusarium 
oxysporum, MTCC: Microbial Type Culture Collection
